E-LIB Suche - Ergebnisse für: Döhner, K

1

Randomized phase-III study of low-dose cytarabine and etopo..:

Schlenk, R. F. ; Weber, D. ; Krzykalla, J....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

2

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 ..:

Hammersen, J. ; Birndt, S. ; Döhner, K....
Leukemia. 37 (2023) 9 - p. 1879-1886 , 2023

Link: https://doi.org/10.1038/..

3

S130: NPM1 MUTATED AML: IMPACT OF CO-MUTATIONAL PATTERNS - ..:

Hernández-Sánchez, A. ; Villaverde-Ramiro, Á. ; Martínez Elicegui, J....
HemaSphere. 6 (2022) - p. 31-32 , 2022

Link: https://doi.org/10.1097/..

4

S106: UBTF-ATXN7L3 GENE FUSION DUE TO 17Q21.31 DELETION DEF..:

Bastian, L. ; Hartmann, A. ; Beder, T....
HemaSphere. 6 (2022) - p. 7-8 , 2022

Link: https://doi.org/10.1097/..

5

P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATI..:

Ruecker, F. G. ; Corbacioglu, A. ; Theis, F....
HemaSphere. 6 (2022) - p. 348-349 , 2022

Link: https://doi.org/10.1097/..

6

P394: INSIGHTS INTO PATIENT-DERIVED XENOGRAFT MODELS FOR DE..:

Charles Cano, F. ; Kloos, A. ; Fangmann, T....
HemaSphere. 6 (2022) - p. 294-295 , 2022

Link: https://doi.org/10.1097/..

7

P532: ACUTE MYELOID LEUKEMIA (AML): UNICENTRIC REPORT ON 10..:

Fricke, A. ; Nachtkamp, K. ; Döhner, K....
HemaSphere. 6 (2022) - p. 431-432 , 2022

Link: https://doi.org/10.1097/..

8

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIA..:

Stegelmann, F. ; Jahn, E. ; Koschmieder, S....
HemaSphere. 6 (2022) - p. 945-946 , 2022

Link: https://doi.org/10.1097/..

9

P456: A LONG READ SEQUENCING AND CRISPR-CAS9 BASED APPROACH..:

Schrezenmeier, J. ; Straeng, J. E. ; Blau, O....
HemaSphere. 6 (2022) - p. 356-357 , 2022

Link: https://doi.org/10.1097/..

10

Randomized phase-II trial evaluating induction therapy with..:

Schlenk, R. F. ; Weber, D. ; Herr, W....
Leukemia. 33 (2019) 8 - p. 1923-1933 , 2019

Link: https://doi.org/10.1038/..

11

DNMT3A mutant transcript levels persist in remission and do..:

for the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG) ; Gaidzik, V I ; Weber, D...
Leukemia. 32 (2017) 1 - p. 30-37 , 2017

Link: https://doi.org/10.1038/..

12

A novel mid-scale screening assay to identify compounds wit..:

Buchmann, B. ; Döhner, K. ; Schirdewahn, T....
Journal of Hepatology. 66 (2017) 1 - p. S258 , 2017

Link: https://doi.org/10.1016/..

13

Impact of pretreatment characteristics and salvage strategy..:

and for the German-Austrian AMLSG ; Schlenk, R F ; Frech, P...
Leukemia. 31 (2017) 5 - p. 1217-1220 , 2017

Link: https://doi.org/10.1038/..

14

Condensed versus standard schedule of high-dose cytarabine ..:

Jaramillo, S ; Benner, A ; Krauter, J...
Blood Cancer Journal. 7 (2017) 5 - p. e564-e564 , 2017

Link: https://doi.org/10.1038/..

15

Reduced-toxicity conditioning for allogeneic hematopoietic ..:

Wais, V ; Kündgen, L ; Bohl, S R...
Bone Marrow Transplantation. 53 (2017) 1 - p. 94-96 , 2017

Link: https://doi.org/10.1038/..